Search Results
Have the ORAL Surveillance results changed clinical practice? | Richard Conway and Kevin Winthrop
ORAL Surveillance Tofacitinib Safety Panel
Further Considerations of the ORAL Surveillance Study
ORAL Surveillance trial: risk of cardiovascular events with tofacitinib vs TNFi in patients with RA
Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors
Expert Panel: Inital Views on FDA Warnings for JAK Inhibitors
September 15, 2022 | Quality Improvement in Your Clinical Practice with Dr. Amna Ahmed
SPD 2022: Session 1 – Recently published clinical practice guidelines
Clinical Application of Recommendations on Use of JAKi in Inflammatory Arthritis (Webinar)
Prof. Kai Zacharowski, Meet the Expert session @ Euroanaesthesia 2020
JAK Therapies: Mechanism of Action, Pharmacotherapeutic Profiles, and Positioning
Dr Joseph Standing: Understanding and applying PKPD concepts in your clinical practice
